Invention Grant
- Patent Title: Inhibitors of CD40-TRAF6 interaction
-
Application No.: US15019581Application Date: 2016-02-09
-
Publication No.: US09750717B2Publication Date: 2017-09-05
- Inventor: Esther Lutgens , Christian Weber , Gerry Nicolaes
- Applicant: Ludwig-Maximilians-Universitaet Muenchen , Maastricht University , Academisch Ziekenhuis Maastricht
- Applicant Address: DE München NL Maastricht
- Assignee: LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN,MAASTRICHT UNIVERSITY
- Current Assignee: LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN,MAASTRICHT UNIVERSITY
- Current Assignee Address: DE München NL Maastricht
- Agency: Saliwanchik, Lloyd & Eisenschenk
- Priority: EP12181862 20120827
- Main IPC: A61K31/381
- IPC: A61K31/381 ; C07D333/22 ; C07C251/24 ; C07C251/26 ; C07D307/52 ; A61K31/137 ; A61K31/341
Abstract:
The present invention relates to compounds acting as selective inhibitors of CD40-TRAF6 interaction, their use as medicaments and their use in the treatment of (chronic) inflammatory diseases. The present invention also relates to pharmaceutical compositions comprising these compounds.
Public/Granted literature
- US20160228408A1 Inhibitors of CD40-TRAF6 Interaction Public/Granted day:2016-08-11
Information query
